JAMES MWATIBO: Open Payments
NPI 1710975487 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 42 payments from 15 companies in 2025. Trend: 2023 $1,025 · 2024 $874 · 2025 $735
Food & beverage: $735
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 11 | $155 |
| Lilly USA, LLC | 8 | $143 |
| ABBVIE INC. | 5 | $98 |
| Dexcom, Inc. | 3 | $59 |
| Novo Nordisk Inc | 3 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| KYOWA KIRIN, INC. | 1 | $25 |
| Abbott Laboratories | 1 | $23 |
Products named: IBSRELA, Dexcom G6 Transmitter, ZEPBOUND, CREON, JARDIANCE, VRAYLAR, MOUNJARO, VOQUEZNA.
Industry payments across LA — which companies pay providers there.
